Multiple fractions per day are being used increasingly in clinical radiotherapy.
There are sound radiobiological reasons for this, but the approach uses more time on treatment machines than conventional radiotherapy.
The effect of using hyperfractionated schedules for a small minority of radically treated patients has been assessed using a previously published model.
The analysis shows that profitability is severely affected by pure hyperfractionation, and that a schedule with a 2-week gap could, by increasing the number of patients it would be possible to treat palliatively, actually increase profitability.
Waiting times for treatment could increase, sometimes to clinically unacceptable levels, for patients in all categories.
Mots-clés Pascal : Tumeur maligne, Radiothérapie, Traitement, Dose fractionnée, Temps attente, Analyse économique, Analyse coût, Economie santé, Angleterre, Grande Bretagne, Royaume Uni, Europe, Homme
Mots-clés Pascal anglais : Malignant tumor, Radiotherapy, Treatment, Fractionated dose, Waiting time, Economic analysis, Cost analysis, Health economy, England, Great Britain, United Kingdom, Europe, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0438941
Code Inist : 002B04H02A. Création : 01/03/1996.